[HTML][HTML] Esophagectomy after anti-reflux surgery
KR Shen, KM Harrison-Phipps, SD Cassivi… - The Journal of thoracic …, 2010 - Elsevier
OBJECTIVE: There are few data on whether prior fundoplication has an impact on
subsequent esophageal resection and reconstruction. The aim of this study is to review our …
subsequent esophageal resection and reconstruction. The aim of this study is to review our …
[HTML][HTML] A robust semi-automatic delineation workflow using denoised diffusion weighted magnetic resonance imaging for response assessment of patients with …
R den Boer, KNW Siang, M Yuen, A Borggreve… - Physics and Imaging in …, 2023 - Elsevier
Abstract Background and Purpose Diffusion weighted magnetic resonance imaging (DW-
MRI) can be prognostic for response to neoadjuvant chemotherapy (nCRT) in patients with …
MRI) can be prognostic for response to neoadjuvant chemotherapy (nCRT) in patients with …
Application of the eighth AJCC TNM staging system in patients with esophageal squamous cell carcinoma
PK Hsu, HS Chen, CC Liu, SC Wu - The Annals of Thoracic Surgery, 2018 - Elsevier
Background The eighth edition of the American Joint Committee on Cancer Tumor-Node-
Metastasis staging system separates classifications for the clinical (c), pathologic (p), and …
Metastasis staging system separates classifications for the clinical (c), pathologic (p), and …
Safety and feasibility of esophagectomy following neoadjuvant immunotherapy combined with chemotherapy for esophageal squamous cell carcinoma
YM Gu, QX Shang, HL Zhang, YS Yang… - Frontiers in …, 2022 - frontiersin.org
Background This study aimed to investigate the safety and feasibility of esophagectomy after
neoadjuvant immunotherapy and chemotherapy for esophageal squamous cell carcinoma …
neoadjuvant immunotherapy and chemotherapy for esophageal squamous cell carcinoma …
Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis
E Hagens, K Tukanova, S Jamel… - Diseases of the …, 2022 - academic.oup.com
Introduction The prognostic value of histomorphologic regression in primary esophageal
cancer has been previously established, however the impact of lymph node (LN) response …
cancer has been previously established, however the impact of lymph node (LN) response …
Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus
E Visser, D Edholm, BM Smithers… - Journal of surgical …, 2018 - Wiley Online Library
Background The optimal treatment strategy for patients with esophageal adenocarcinoma
(EAC) remains undetermined. This study compared outcomes in patients undergoing …
(EAC) remains undetermined. This study compared outcomes in patients undergoing …
Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer
Background A pathologically complete response (pCR) to neoadjuvant chemoradiotherapy
(nCRT) is seen in 30% of the patients with oesophageal cancer. The aim is to identify patient …
(nCRT) is seen in 30% of the patients with oesophageal cancer. The aim is to identify patient …
Nuclear medicine radiomics in digestive system tumors: Concept, applications, challenges, and future perspectives
W Huang, Z Tao, MH Younis, W Cai, L Kang - View, 2023 - Wiley Online Library
Radiomics aims to develop novel biomarkers and provide relevant deeper subvisual
information about pathology, immunophenotype, and tumor microenvironment. It uses …
information about pathology, immunophenotype, and tumor microenvironment. It uses …
The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response
AU Blackham, B Yue, K Almhanna… - Journal of Surgical …, 2015 - Wiley Online Library
Background The prognostic significance of residual nodal disease in otherwise complete
pathologic responders (ypT0N+) to neoadjuvant chemoradiation (nCRT) for esophageal …
pathologic responders (ypT0N+) to neoadjuvant chemoradiation (nCRT) for esophageal …
The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
Background Neoadjuvant programmed death receptor-1 (PD-1) inhibitor combined with
chemotherapy has been reported to improve the pathological response of locally advanced …
chemotherapy has been reported to improve the pathological response of locally advanced …